There will be a strong focus at this conference on mechanisms. We are planning general sessions that will highlight some of the important efforts to characterize the mechanism of action of enzymes that catalyze a diverse set of chemical reactions of small molecules and more complex substrates; and, on the mechanisms of specialized cofactors that have been recruited by enzymes. In addition, there will be focused sessions on: (i) the mechanism of action of enzymes that catalyze reactions at membrane surfaces, (ii) protein catalysts that use RNA and DNA as substrates, and RNA catalysts that use small molecules as substrates, (iii) development of enzyme inhibitors as therapeutic agents, and (iv) frontiers of mechanistic enzymology

Contributors:

ACS Division of Biological Chemistry
Abbott Laboratories
ActivX Biosciences, Inc.
Amgen
AstraZeneca R&D Boston - Infection Discovery
AstraZeneca UK Limited
Biogen Idec, Inc.
Cargill Incorporated
Cell Press
E.I. Dupont de Nemours & Co.
GlaxoSmithKline
Merck Research Laboratories
Monsanto Company
National Institutes of Health - NIGMS
New England Biolabs
Novartis Institutes for Biomedical Research
Pfizer
Royal Society of Chemistry - Molecular Biosystems
Schering-Plough
Takeda San Diego
TransForm Pharmaceuticals, Inc.
Wyeth Research